Tirzepatide is a glucose-dependent insulinotropic polypeptide (GIP) and GLP-1 receptor agonist that mimics the GLP-1 and GIP hormones
Meaningful price premium is justified by: verified copper tripeptide-1 concentration (not just "copper peptide complex"), stable packaging (airless or amber glass), a pH between 5.5 and 7.0 confirmed by the brand, absence of destabilizing ingredients like high-dose vitamin C in the same formula, and a third-party COA for the active ingredient
This receptor profile has unique physiological effects, such as a noticeable decrease in stomach motility and brainstem-mediated signals of fullness
This benefit extends beyond weight loss alone
Weight Loss Current FDA label Tablet or injection routes Long-term plan review Cardiovascular Health FDA CV risk indication SELECT trial backed 20% lower CV risk Metabolic Function Better glucose control Improved A1C Lipid panel gains Appetite Control Slows gastric emptying Reduces food noise Route-specific routine Lose weight with FDA-approved care
Methanol (VWR Chemicals), formic acid (Sigma-Aldrich, West Chester, PA, USA) & DMSO Sigma-Aldrich (West Chester, PA, USA), NADPH (Merk, USA)